Clinical Effects

Based on observed response in clinical trials, therapy with EECP can offer symptomatic and clinical relief in patients with angina pectoris, including :

• Reduced need for antianginal medications
• Reduced frequency and intensity of chest pain
• Increased exercise tolerance
• Immediate and sustained improvement in myocardial perfusion of ischemic areas

As a result of symptomatic and clinical improvements, patients have reported an improved sense of well-being and overall improvement in quality of life.